The U.S. National Institutes of Health (NIH) has set an initiative in motion that intents to banish a biomedical research bias toward the use of male animal models and cells in preclinical studies.

Watch a presentation on nanoconstructs in cancer theranostics from the Methodist Hospital Research Institute and Tel Aviv University (TAU) posted online from the recent Summer School on Nanomedicine and Innovation.

Makers of F-18 florbetapir (Amyvid) are bankrolling a lawsuit against the Centers for Medicare & Medicaid Services (CMS), which hampered coverage of amyloid imaging earlier this year as a means for ruling out Alzheimer’s disease. The lawsuit was filed in federal court by Lilly and others Sept. 5, according to this Wall Street Journal report.

The Centers for Medicare & Medicaid Services (CMS) has provided projected U.S. healthcare spending for the next several years and it is modest. Due to a timid economy and higher private insurance plan costs that pinch demand for healthcare services, average annual healthcare spending is expected to grow by 5.7 percent this year and just about 6 percent from 2013 to 2023.

In the world of cancer screening, there may be a bias of accessibility that is skewed toward more screening when doctors are paid more by Medicaid, according to a study conducted by the division of health services and social policy research at RTI International in Washington, D.C.

Researchers from the University of California, Davis, have created dynamic nanoparticles that can be used to both diagnose and treat cancer.

Chronic pain is associated with a reduction in reward seeking, but not just because people are hurting and do not feel up to the task. New Stanford brain research is providing a more comprehensive picture of how molecular changes in the brain dictate loss of motivation in painful settings.

It is easy to create generics from conventional drugs, but not so for biologics, which involve active biological ingredients such as proteins that can be leveraged to treat cancer and a range of other diseases. Biosimilars, which mimic biologics as closely as possible, could be the next big thing in the U.S., but a hot debate has been pitched over what to name these drugs.

A treatment for stroke involving optogenetics fires up neurons in the motor cortex by way of a beam of light. This treatment has been shown in preclinical research to improve movement and coordination after a stroke, say researchers at Stanford University in Stanford, Calif.

Plato's Cave, short for computer augmented virtual environment, is a 5D imaging masterpiece engineered by researchers at the Methodist Hospital in Houston that combines PET, MR and CT imaging on multiple screens, including a touch-screen table top, and the ability to use voice commands and game controllers to manipulate and fly-through medical images for better treatment planning.

It may seem like an unlikely connection, but an aversion to kitty litter has led to a very interesting discovery about post-traumatic stress disorder (PTSD) that could one day lead to a diagnostic test and perhaps even a drug therapy,

A New York Times piece reviews recent research on the safety of potential Alzheimer’s therapies that focus on genetic factors of the disease. APOE is a hallmark risk factor and perhaps the most common in those who progress to Alzheimer’s, and often earlier than others.